LivaNova enrols first patient in OSPREY study of aura6000 system
The study will evaluate the safety and effectiveness of the LivaNova aura6000 system, an implantable hypoglossal neurostimulator to…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
25 Feb 22
The study will evaluate the safety and effectiveness of the LivaNova aura6000 system, an implantable hypoglossal neurostimulator to…
25 Feb 22
In preclinical testing, RaniPill HC demonstrated successful delivery of adalimumab and achieved high bioavailability
25 Feb 22
Flowflex is authorized by FDA under an EUA and has the CE Mark for self-testing, is available in…
25 Feb 22
The new integration will help centralise patient data to help clinicians to monitor postoperative recovery and care plan…
25 Feb 22
SkylineDx is a biotechnology company, focused on research & development of molecular diagnostics in oncology and inflammatory diseases
24 Feb 22
The acquisition of Kumovis will allow 3D Systems to add an advanced extrusion technology to its polymer printing…
24 Feb 22
NephroScan is a sterile, single-dose kit designed for the preparation of radiopharmaceutical agent technetium Tc 99m succimer injection
24 Feb 22
Over six million tests have been performed and analyzed using the HDPCR SARS-CoV-2 EUA assay and ChromaCode Cloud
24 Feb 22
The BEE PLIF cage is another significant innovation from the team who invented the first line of additively…
24 Feb 22
LIVOx is the first monitoring device to non-invasively monitor sepsis by detecting a key indicator of septic shock